Nanoparticles: Emerging carriers for drug delivery

Saudi Pharmaceutical Journal

Volumn 19, Issue 3, 2011, Pages 129-141

  Mudshinge, Sagar R ^a   Deore, Amol B ^b   Patil, Sachin ^c   Bhalgat, Chetan M ^d  

^a Department of Pharmacology   (India)

^b NDMVP's Institute of Pharmaceutical Sciences   (India)

^c Mayani College of Pharmacy   (India)

^d Sri Adichunchanagiri College of Pharmacy   (India)

Author keywords

Biomacromolecular; Diagnostics; Nanoparticles; Nanoscale; Nanostructures; Supramolecular

Indexed keywords

DENDRIMER; DRUG VEHICLE; FULLERENE DERIVATIVE; LIPOSOME; NANOMATERIAL; NANOPARTICLE; NANOSHELL; NANOSTRUCTURED LIPID CARRIER; QUANTUM DOT; SOLID LIPID NANOPARTICLE; SUPERPARAMAGNETIC NANOPARTICLE; UNCLASSIFIED DRUG;

DRUG DELIVERY SYSTEM; DRUG RELEASE; PARTICLE SIZE; PHARMACEUTICS; REVIEW;

EID: 79957967637     PISSN: 13190164     EISSN: 13190164     Source Type: Journal    
DOI: 10.1016/j.jsps.2011.04.001     Document Type: Review

References (174)

1. Abeylath S.C., Turos E., Dickey S., Lim D.V. Glyconanobiotics: novel carbohydrated nanoparticle antibiotics for MRSA and Bacillus anthracis. Bioorg. Med. Chem. 2008, 16(5):2412-2418.
2. Abhilash M. Potential applications of Nanoparticles. Int. J. Pharm.Bio Sci. 2010, 1(1):1-12.
3. Agrawal A., Tripp R.A., Anderson L.J., Nie S.M. Real-time detection of virus particles and viral protein expression with two-color nanoparticle probes. J. Virol. 2005, 79(13):8625-8628.
4. Akerman M.E., Chan W.C.W., Laakkonen P., Bhatia S.N., Ruoslahti E. Nanocrystal targeting in vivo. Proc. Natl. Acad. Sci. USA 2002, 99(20):12617-12621.
5. Alivisatos P. The use of nanocrystals in biological detection. Nat. Biotechnol. 2004, 22(1):47-52.
6. Azzam T., Domb A.J. Current developments in gene transfection agents. Curr. Drug Deliv. 2004, 1(2):165-193.
7. Babic M., Horák D., Trchová M., Jendelová P., Glogarová K., Lesný P., Herynek V., Hájek M., Syková E. Poly(l-lysine)-modified iron oxide nanoparticles for stem cell labeling. Bioconjug. Chem. 2008, 19(3):740-750.
8. Bai S., Thomas C., Ahsan F. Dendrimers as a carrier for pulmonary delivery of enoxaparin, a low molecular weight heparin. J. Pharm. Sci. 2007, 96(8):2090-2106.
9. Bhadra D., Bhadra S., Jain N.K. Pegylated lysine based copolymeric dendritic micelles for solubilization and delivery of artemether. J. Pharm. Pharm. Sci. 2005, 8(3):467-482.
10. Bhalekar M.R., Pokharkar V., Madgulkar A., Patil N., Patil N. Preparation and evaluation of miconazole nitrate-loaded solid lipid nanoparticles for topical delivery. AAPS Pharm. Sci. Tech. 2009, 10(1):289-296.
11. Bhaskar K., Anbu J., Ravichandiran V., Venkateswarlu V., Rao Y.M. Lipid nanoparticles for transdermal delivery of flurbiprofen: formulation, in vitro, ex vivo and in vivo studies. Lipids Health Dis. 2009, 8:6.
12. Brettreich M., Hirsch A. A highly water-soluble dendro[60]fullerene. Tetrahedron Lett. 1998, 39(18):2731-2734.
13. Buzea C., Pacheco I., Robbie K. Nanomaterials and nanoparticles: sources and toxicity. Biointerphases 2007, 2:MR17-MR71.
14. Cavalli R., Caputo O., Gasco M.R. Solid lipospheres of doxorubicin and idarubicin. Int. J. Pharm. 1993, 89(1):R9-R12.
15. Cavalli R., Morel S., Gasco M.R., Chetoni P., Saettone M.F. Preparation and evaluation in vitro of colloidal lipospheres containing pilocarpine as ion pair. Int. J. Pharm. 1995, 117(2):243-246.
16. Cavalli R., Gasco M.R., Chetoni P., Burgalassi S., Saettone M.F. Solid lipid nanoparticles (SLN) as ocular delivery system for tobramycin. Int. J. Pharm. 2002, 238(1-2):241-245.
17. Cevc G. Transfersomes, liposomes and other lipid suspensions on the skin: permeation enhancement, vesicle penetration, and transdermal drug delivery. Crit. Rev. Ther. Drug Career Syst. 1996, 13(3-4):257-388.
18. Chauhan A.S., Sridevi S., Chalasani K.B., Jain A.K., Jain S.K., Jain N.K., Diwan P.V. Dendrimer-mediated transdermal delivery: enhanced bioavailability of indomethacin. J. Control Rel. 2003, 90(3):335-343.
19. Chen Y., McCulloch R.K., Gray B.N. Synthesis of albumin-dextran sulfate microspheres possessing favourable loading and release characteristics for the anti-cancer drug doxorubicin. J. Control Rel. 1994, 31(1):49-54.
20. Cheng Y., Man N., Xu T., Fu R., Wang X., Wang X., Wen L. Transdermal delivery of nonsteroidal anti-inflammatory drugs mediated by polyamidoamine (PAMAM) dendrimers. J. Pharm. Sci. 2007, 96(3):595-602.
21. Cheng Y., Qu H., Ma M., Xu Z., Xu P., Fang Y., Xu T. Polyamidoamine (PAMAM) dendrimers as biocompatible carries of quinolone antimicrobials: an in vitro study. Eur. J. Med. Chem. 2007, 42(7):1032-1038.
22. Chiang C.L., Sung C.S., Wu T.F., Chen C.Y., Hsu C.Y. Application of superparamagnetic nanoparticles in purification of plasmid DNA from bacterial cells. J. Chromat. B 2005, 822(1-2):54-60.
23. Choi A.O., Cho S.J., Desbarats J., Lovric J., Maysinger D. Quantum dot-induced cell death involves Fas upregulation and lipid peroxidation in human neuroblastoma cells. J. Nanobiotechnol. 2007, 5:1-4.
24. Choi H.S., Liu W., Misra P., Tanaka E., Zimmer J.P., Ipe B.I., Bawendi M.G., Frangion J.V. Renal clearance of quantum dots. Nat. Biotechnol. 2007, 25(10):1165-1170.
25. Culver K.W. Clinical applications of gene therapy for cancer. Clin. Chem. 1994, 40(4):510-512.
26. Davies R., Schurr G.A., Meenam P., Nelson R.D., Bergna H.E., Brevett C.A.S., Goldbaum R.H. Engineered particle surfaces. Adv. Mater. 1998, 10(15):1264-1270.
27. Day R.N., Periasamy A., Schaufele F. Fluorescence resonance energy transfer microscopy of localized protein interactions in the living cell nucleus. Methods 2001, 25(1):4-18.
28. D'Emanuele A., Jevprasesphant R., Penny J., Atwood D. The use of a dendrimer-propranolol prodrug to bypass efflux transporters and oral bioavailability. J. Control. Release 2004, 95(3):447-453.
29. Derfus A.M., Chan W.C.W., Bhatia S.N. Intracellular delivery of quantum dots for live cell labeling and organelle tracking. Adv. Mater. 2004, 16(12):961-966.
30. Devarakonda B., Hill R.A., Liebenberg W., Brits M., de Villiers M.M. Comparison of the aqueous solubilization of practically insoluble niclosamide by polyamidoamine (PAMAM) dendrimers and cyclodextrins. Int. J. Pharm. 2005, 304(1-2):193-209.
31. Di Paolo D., Loi M., Pastorino F., Brignole C., Marimpietri D., Becherini P., Caffa I., Zorzoli A., Longhi R., Gagliani C., Tacchetti C., Corti A., Allen T.M., Ponzoni M., Pagnan G. Liposome-mediated therapy of neuroblastoma. Methods Enzymol. 2009, 465:225-249.
32. Doktorovová S., Araújo J., Garcia M.L., Rakovský E., Souto E.B. Formulating fluticasone propionate in novel PEG-containing nanostructured lipid carriers (PEG-NLC). Colloids Surf. B: Biointerf. 2010, 75(2):538-542.
33. Domb A.J. Liposphere parenteral delivery system. Proc. Intl. Symp. Control Rel. Bioact. Mater. 1993, 20:346-347.
34. Dubertret B., Skourides P., Norris D.J., Noireaux V., Brivanlou A.H., Libchaber A. In vivo imaging of quantum dots encapsulated in phospholipid micelles. Science 2002, 298(5599):1759-1762.
35. Dugan L.L., Turetsky D.M., Du C., Lobner D., Wheeler M., Almli C.R., Shen C.K., Luh T.Y., Choi D.W., Lin T.S. Carboxyfullerenes as neuroprotective agents. Proc. Natl. Acad. Sci. USA 1997, 94(17):9434-9439.
36. Eldem T., Speiser P., Hincal A. Optimization of spray-dried and congealed lipid microparticles and characterization of their surface morphology by scanning electron microscopy. Pharm. Res. 1991, 8:47-54.
37. Euliss L.E., Grancharov S.G., O'Brien S., Deming T.J., Stucky G.D., Murray C.B., Held G.A. Cooperative Assembly of Magnetic Nanoparticles and Block Copolypeptides in Aqueous Media. Nano Lett. 2003, 3(11):1489-1493.
38. Fielding R.M., Lewis R.O., Moon-McDermott L. Altered tissue distribution and elimination of amikacin encapsulated in unilamellar, low-clearance liposomes (MiKasome). Pharm. Res. 1998, 15(11):1775-1781.
39. Fontana G., Maniscalco L., Schillaci D., Cavallaro G., Giammona G. Solid lipid nanoparticles containing tamoxifen characterization and in vitro antitumoral activity. Drug Deliv. 2005, 12(6):385-392.
40. Freitas C., Müller R.H. Spray-drying of Solid lipid nanoparticles (SLNTM). Eur. J. Pharm. Biopharm. 1998, 46(2):145-151.
41. Friedman S.H., DeCamp D.L., Sijbesma R.P., Srdanov G., Wudl F., Kenyon G.L. Inhibition of the HIV-1 protease by fullerene derivatives: model building studies and experimental verification. J. Am. Chem. Soc. 1993, 115(15):6506-6509.
42. Gangadharam P.R., Ashtekar D.A., Ghori N., Goldstein J.A., Debs R.J., Duzgunes N. Chemotherapeutic potential of free and liposome encapsulated streptomycin against experimental Mycobacterium avium complex infections in beige mice. J. Antimicrob. Chemother. 1991, 28(3):425-435.
43. Gao X.H., Cui Y.Y., Levenson R.M., Chung L.W.K., Nie S.M. In vivo cancer targeting and imaging with semiconductor quantum dots. Nat. Biotechnol. 2004, 22:969-976.
44. Gerion D., Parak W.J., Williams S.C., Zanchet D., Micheel C.M., Alivisatos A.P. Sorting fluorescent nanocrystals with DNA. J. Am. Chem. Soc. 2002, 124(24):7070-7074.
45. Gerion D., Chen F.Q., Kannan B., Fu A.H., Parak W.J., Chen D.J., Majumdar A., Alivisatos A.P. Room-temperature single-nucleotide polymorphism and multiallele DNA detection using fluorescent nanocrystals and microarrays. Anal. Chem. 2003, 75(18):4766-4772.
46. Ghazani A.A., Lee J.A., Klostranec J., Xiang Q., Dacosta R.S., Wilson B.C., Tsao M.S., Chan W.C. High throughput quantification of protein expression of cancer antigens in tissue microarray using quantum dot nanocrystals. Nano Lett. 2006, 6(12):2881-2886.
47. Goldman E.R., Anderson G.P., Tran P.T., Mattoussi H., Charles P.T., Mauro J.M. Conjugation of luminescent quantum dots with antibodies using an engineered adaptor protein to provide new reagents for fluoroimmunoassays. Anal. Chem. 2002, 74(4):841-847.
48. Grayson S.M., Frechet J.M. Convergent dendrons and dendrimers: from synthesis to applications. Chem. Rev. 2001, 101(12):3819-3868.
49. Gupta A.K., Curtis A.S.G. Lactoferrin and ceruloplasmin derivatized superparamagnetic iron oxide nanoparticles for targeting cell surface receptors. Biomaterials 2004, 25(15):3029-3040.
50. Gupta A.K., Gupta M. Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. Biomaterials 2005, 26(18):3995-4021.
51. Hasegawa U., Nomura S.I.M., Kaul S.C., Hirano T., Akiyoshi K. Nanogel-quantum dot hybrid nanoparticles for live cell imaging. Biochem. Biophys. Res. Commun. 2005, 331(4):917-921.
52. Hawthorne M.F. The role of chemistry in the development of boron neutron capture therapy of cancer. Angew. Chem. 1993, 32(7):950-984.
53. Hentschel A., Gramdorf S., Müller R.H., Kurz T. Beta-carotene-loaded nanostructured lipid carriers. J. Food Sci. 2008, 73(2):1-6.
54. Heyduk T. Measuring protein conformational changes by FRET/ LRET. Curr. Opin. Biotechnol. 2002, 13(4):292-296.
55. Hirsch L.R., Jackson J.B., Lee A., Halas N.J., West J.L. A whole blood immunoassay using gold nanoshells. Anal. Chem. 2003, 75(10):2377-2381.
56. Hirsch L.R., Stafford R.J., Bankson J.A., Sreshen S.R., Rivera B., Price R.E., Hazle J.D., Halas N.J., West J.L. Nanoshell-mediated near-infrared thermal therapy of tumours under magnetic resonance guide. Proc. Natl. Acad. Sci. USA 2003, 100(23):13549-13554.
57. Hodge P. Polymer science branches out. Nature 1993, 362:18-19.
58. Hofmann-Amtenbrink, M., von Rechenberg, B., Hofmann, H., 2009. Superparamagnetic nanoparticles for biomedical applications. In: Nanostructured Materials for Biomedical Applications. Transworld Research Network, Kearala, India, pp. 119-149.
59. Hohng S., Ha T. Single-molecule quantum-dot fluorescence resonance energy transfer. Chemphyschem 2005, 6(5):956-960.
60. Holister, P., Cristina, R.V., Fullerenes, H.T., 2003. Nanoparticles, Technology White papers nr. 3, Cientifica 1-12.
61. Horák D. Magnetic microparticulate carriers with immobilized selective ligands in DNA diagnostics. Polym. 2005, 46(4):1245-1255.
62. Hu F.Q., Jiang S.P., Du Y.Z., Yuan H., Ye Y.Q., Zeng S. Preparation and characteristics of monostearin nanostructured lipid carriers. Int. J. Pharm. 2006, 314(1):83-89.
63. Huang Y.L., Shen C.K.F., Luh T.Y., Yang H.C., Hwang K.C., Chou C.K. Blockage of apoptotic signaling of transforming growth factor-β in human hepatoma cells by carboxyfullerene. Eur. J. Biochem. 1998, 254:38-43.
64. Irving B. Nanoparticle drug delivery systems. Inno. Pharm. Biotechnol. 2007, 24:58-62.
65. Jain D., Banerjee R. Comparison of ciprofloxacin hydrochlorideloaded protein, lipid, and chitosan nanoparticles for drug delivery. J. Biomed. Mater. Res. B. Appl. Biomater. 2008, 86(1):105-112.
66. Jain A., Jain S.K., Ganesh N., Barve J., Beg A.M. Design and development of ligand-appended polysaccharidic nanoparticles for the delivery of oxaliplatin in colorectal cancer. Nanomed. 2009, 6(1):179-190.
67. Jain P., Mishra A., Yadav S.K., Patil U.K., Baghel U.S. Formulation development and characterization of solid lipid nanoparticles containing nimesulide. Int. J. Drug Deliver Technol. 2009, 1(1):24-27.
68. Jaiswal J.K., Mattoussi H., Mauro J.M., Simon S.M. Long-term multiple color imaging of live cells using quantum dot bioconjugates. Nat. Biotechnol. 2003, 21(1):47-51.
69. Jakub J.W., Pendas S., Reintgen D.S. Current status of sentinel lymph node mapping and biopsy: facts and controversies. Oncologist 2003, 8(1):59-68.
70. Jenning V., Gysler A., Schafer-Korting M., Gohla S. Vitamin A loaded solid lipid nanoparticles for topical use: occlusive properties and drug targeting to the upper skin. Eur. J. Pharm. Biopharm. 2000, 49(3):211-218.
71. Jordan A., Scholz R., Wust P., Fähling H., Felix R. Magnetic fluid hyperthermia (MFH): cancer treatment with AC magnetic field induced excitation of biocompatible superparamagnetic nanoparticles. J. Magn. Magn. Mater. 1999, 201(1-3):413-419.
72. Jordan A., Scholz R., Maier-Hauff K., Johannsen M., Wust P., Nadobny J., Schirra H., Schmidt H., Deger S., Loening S., Lanksch W., Felix R. Presentation of a new magnetic field therapy system for the treatment of human solid tumors with magnetic fluid hyperthermia. J. Magn. Magn. Mater. 2001, 225(1-2):118-126.
73. Kaesermann F., Kempf C. Photodynamic inactivation of enveloped viruses by buckminsterfullerene. Antiviral Res. 1997, 34(1):65-70.
74. Kagan C.R., Murray C.B., Nirmal M., Bawendi M.G. Electronic energy transfer in CdSe quantum dot solids. Phys. Rev. Lett. 1996, 76(9):1517-1520.
75. Kalele S.A., Ashtaputre S.S., Hebalkar N.Y., Gosavi S.W., Deobagkar D.N., Deobagkar D.D., Kulkarni S.K. Optical detection of antibody using silica-silver core-shell particles. Chem. Phys. Lett. 2005, 404(1-3):136-141.
76. Kalele S.A., Gosavi S.W., Urban J., Kulkarni S.K. Nanoshell particles: synthesis, properties and applications. Curr. Sci. 2006, 91(8):1038-1052.
77. Kalele S.A., Kundu A.A., Gosavi S.W., Deobagkar D.N., Deobagkar D.D., Kulkarni S.K. Rapid detection of Echerischia coli using antibody conjugated silver nanoshells. Small. 2006, 2(3):335-338.
78. Kaur C.D., Nahar M., Jain N.K. Lymphatic targeting of zidovudine using surface-engineered liposomes. J. Drug Target 2008, 16(10):798-805.
79. Khairnar G.A., Chavan-Patil A.B., Palve P.R., Bhise S.B., Mourya V.K., Kulkarni C.G. Dendrimers: potential tool for enhancement of antifungal activity. Int. J. Pharm. Tech. Res. 2010, 2(1):736-739.
80. Kim H.J., Jones M.N. The delivery of benzyl penicillin to Staphylococcus aureus biofilms by use of liposomes. J. Liposome Res. 2004, 14(3-4):123-139.
81. Kobayashi H., Brechbiel M.W. Dendrimer-based macromolecular MRI contrast agents: characteristics and application. Mol. Imaging 2003, 2(1):1-10.
82. Kotelnikova R.A., Bogdanov G.N., Frog E.C., Kotelnikov A.I., Shtolko V.N., Romanova V.S., Andreev S.M., Kushch A.A., Fedorva N.E., Medzhidova A.A., Miller G.G. Nanobionics of pharmacologically active derivatives of fullerene C60. J. Nanoparticle Res. 2003, 5:561-566.
83. Krusic P.J., Wasserman E., Keizer P.N., Morton J.R., Preston K.F. Radical reactions of C60. Science 1991, 254(5035):1183-1185.
84. Kukowska-Latallo J.F., Candido K.A., Cao Z., Nigavekar S.S., Majoros I.J., Thomas T.P., Balogh L.P., Khan M.K., Baker J.R. Nanoparticle targeting of anticancer drug improves therapeutic response in animal model of human epithelial cancer. Cancer Res. 2005, 65(12):5317-5324.
85. Lee L.Y., Ong S.L., Hu J.Y., Ng W.J., Feng Y.Y., Tan X., Wong S.W. Use of semiconductor quantum dots for photostable immunofluorescence labeling of Cryptosporidium parvum. Appl. Environ. Microbiol. 2004, 70(10):5732-5736.
86. Li J.J., Bugg T.D. A fluorescent analogue of UDP-N-acetylglucosamine: application for FRET assay of peptidoglycan translocase II (MurG). Chem. Commun. 2004, 2:182-183.
87. Lim Y.T., Kim S., Nakayama A., Stott N.E., Bawendi M.G., Frangioni J.V. Selection of quantum dot wavelengths for biomedical assays and imaging. Mol. Imaging 2003, 2(1):50-64.
88. Liz-Marzan L.M., Correa-Duarte M.A., Pastoriza-Santos I., Mulvaney P., Ung T., Giersig M., Kotov N.A. Core-shell and assemblies thereof. Hand Book of Surfaces and Interfaces of Materials 2001, 189-237. Elsevier, Amsterdam, Netherlands. H.S. Nalwa (Ed.).
89. Loo C., Lin A., Hirsch L., Lee M., Barton J., Halas N., West J., Drezek R. Nanoshell-enabled photonics-based imaging and therapy of cancer. Technol. Cancer Res. Treat. 2004, 3(1):33-40.
90. Ma M., Cheng Y., Xu Z., Xu P., Qu H., Fang Y., Xu T., Wen L. Evaluation of Polyamidoamine (PAMAM) dendrimers as drug carriers of antibacterial drugs using sulfamethoxazole (SMZ) as a model drug. Eur. J. Med. Chem. 2007, 42(1):93-98.
91. Magallanes M., Dijkstra J., Fierer J. Liposome-incorporated ciprofloxacin in treatment of murine salmonellosis. Antimicrob. Agents Chemother. 1993, 37(11):2293-2297.
92. Marchesan S., Da Ros T., Spalluto G., Balzarini J., Prato M. Anti-HIV properties of cationic fullerene derivatives. Bioorg. Med. Chem. Lett. 2005, 15(15):3615-3618.
93. Mashino T., Shimotohno K., Ikegami N., Nishikawa D., Okuda K., Takahashi K., Nakamura S., Mochizuki M. Human immunodeficiency virus-reverse transcriptase inhibition and hepatitis C virus RNA-dependent RNA polymerase inhibition activities of fullerene derivatives. Bioorg. Med. Chem. Lett. 2005, 15(4):1107-1109.
94. Matsumura Y., Maeda H. A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res. 1986, 46(12):6387-6392.
95. McIlwain C.C. XPharm: The Comprehensive Pharmacology 2008, Elsevier, Amsterdam, Netherlands, pp. 1-5.
96. Medintz I.L., Uyeda H.T., Goldman E.R., Mattoussi H. Quantum dot bioconjugates for imaging, labeling and sensing. Nat. Mater. 2005, 4(6):435-446.
97. Mehnert W., Mäder K. Solid lipid nanoparticles: production, characterization and applications. Adv. Drug Deliver Rev. 2001, 47(2-3):165-196.
98. Meng J., Fan J., Galiana G., Branca R.T., Clasen P.L., Ma S., Zhou J., Leuschner C., Kumar C.S.S.R., Hormes J., Otiti T., Beye A.C., Harmer M.P., Kiely C.J., Warren W., Haataja M.P., Soboyejo W.O. LHRH-functionalized superparamagnetic iron oxide nanoparticles for breast cancer targeting and contrast enhancement in MRI. Mat. Sci. Eng. C 2009, 29(4):1467-1479.
99. Michalet X., Pinaud F.F., Bentolila L.A., Tsay J.M., Doose S., Li J.J., Sundaresan G., Wu A.M., Gambhir S.S., Weiss S. Quantum dots for live cells, in vivo imaging, and diagnostics. Science 2005, 307(5709):538-544.
100. Mimoso I.M., Francisco A.P.G., Cruz M.E.M. Liposomal formulation of netilmicin. Int. J. Pharm. 1997, 147(1):109-117.
101. Minard K.R. Magnetic Particle Imaging. Encyclopedia of Spectroscopy and Spectrometry 2009, Elsevier, Amsterdam, Netherlands, pp. 1426-1434. second ed.
102. Mitchell D.R., Brown R.M., Spires T.L., Romanovicz D.K., Lagow R.J. The synthesis of megatubes: new dimensions in carbon materials. Inorg. Chem. 2001, 40(12):2751-2755.
103. Mohanraj V.J., Chen Y. Nanoparticles: a review. Trop. J. Pharm. Res. 2006, 5(1):561-573.
104. Morishige K., Kacher D.F., Libby P., Josephson L., Ganz P., Weissleder R., Aikawa M. High-resolution magnetic resonance imaging enhanced with superparamagnetic nanoparticles measures macrophage burden in atherosclerosis. Circulation 2010, 122(17):1707-1715.
105. Müller R.H., Runge S.A. Solid lipid nanoparticles (SLN) for controlled drug delivery. Submicron Emulsions in Drug Targeting and Delivery 1998, 219-234. Harwood Academic Publishers, Amsterdam. S. Benita (Ed.).
106. Müller R.H., Maabenb S., Weyhersa H., Spechtb F., Lucksb J.S. Cytotoxicity of magnetite-loaded polylactide, polylactide/glycolide particles and solid lipid nanoparticles. Int. J. Pharm. 1996, 138(1):85-94.
107. Müller R.H., Mader K., Gohla S. Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art. Eur. J. Pharm. Biopharm. 2000, 50(1):161-177.
108. Müller R.H., Radtke M., Wissing S.A. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. Adv. Drug Deliver. Rev. 2002, 54:S131-S155.
109. Neuberger T., Schöpf B., Hofmann H., Hofmann M., von Rechenberg B. Superparamagnetic nanoparticles for biomedical applications: possibilities and limitations of a new drug delivery system. J. Magn. Magn. Mater. 2005, 293(1):483-496.
110. Oldenberg S.J., Averitt R.D., Westcott S.L., Halas N.J. Nanoengineering of optical resonances. Chem. Phys. Lett. 1998, 288(2-4):243-247.
111. Omri A., Suntres Z.E., Shek P.N. Enhanced activity of liposomal polymyxin B against Pseudomonas aeruginosa in a rat model of lung infection. Biochem. Pharmacol. 2002, 64(9):1407-1413.
112. Onyeji C.O., Nightingale C.H., Marangos M.N. Enhanced killing of methicillin-resistant Staphylococcus aureus in human macrophages by liposome-entrapped vancomycin and teicoplanin. Infection 1994, 22(5):338-342.
113. Pandey R., Khuller G.K. Solid lipid particle-based inhalable sustained drug delivery system against experimental tuberculosis. Tuberculosis (Edinb) 2005, 85(4):227-234.
114. Panga X., Cui F., Tian J., Chen J., Zhou J., Zhou W. Preparation and characterization of magnetic solid lipid nanoparticles loaded with ibuprofen. Asian J. Pharm. Sci. 2009, 4(2):132-137.
115. Parak W.J., Boudreau R., Le Gros M., Gerion D., Zanchet D., Micheel C.M., Williams S.C., Alivisatos A.P., Larabell C.A. Cell motility and metastatic potential studies based on quantum dot imaging of phagokinetic tracks. Adv. Mater. 2002, 14(12):882-885.
116. Park J.W. Liposome-based drug delivery in breast cancer treatment. Breast Cancer Res. 2002, 4(3):95-99.
117. Pathak S., Choi S.K., Arnheim N., Thompson M.E. Hydroxylated quantum dots as luminescent probes for in situ hybridization. J. Am. Chem. Soc. 2001, 123(17):4103-4104.
118. Qi L., Gao X. Emerging application of quantum dots for drug delivery and therapy. Expert Opin. Drug Deliv. 2008, 5(3):63-67.
119. Radtke M., Müller R.H. Novel concept of topical cyclosporine delivery with supersaturated SLN™ creams. Int. Symp. Control Rel. Bioact. Mater. 2001, 28:470-471.
120. Ruckmani K., Sivakumar M., Ganeshkumar P.A. Methotrexate loaded solid lipid nanoparticles (SLN) for effective treatment of carcinoma. J. Nanosci. Nanotechnol. 2006, 6(9-10):2991-2995.
121. Rupp R., Rosenthal S.L., Stanberry L.R. VivaGel (SPL7013 Gel): a candidate dendrimer-microbicide for the prevention of HIV and HSV infection. Int. J. Nanomed. 2007, 2(4):561-566.
122. Sanna V., Gavini E., Cossu M., Rassu G., Giunchedi P. Solid lipid nanoparticles (SLN) as carriers for the topical delivery of econazole nitrate: in-vitro characterization, ex-vivo and in-vivo studies. J. Pharm. Pharmacol. 2007, 59(8):1057-1064.
123. Sano N., Wang H., Chhowalla M., Alexandrou I., Amaratunga G.A.J. Synthesis of carbon 'onions' in water. Nature 2001, 414(6863):506-507.
124. Sarmento B., Martins S., Ferreira D., Souto E.B. Oral insulin delivery by means of solid lipid Nanoparticles. Int. J. Nanomed. 2007, 2(4):743-749.
125. Schiffelers R., Storm G., Bakker-Woudenberg I. Liposomeencapsulated aminoglycosides in pre-clinical and clinical studies. J. Antimicrob. Chemother. 2001, 48(3):333-344.
126. Schumacher I., Margalit R. Liposome-encapsulated ampicillin: physicochemical and antibacterial properties. J. Pharm. Sci. 1997, 86(5):635-641.
127. Schumann H., Wassermann B.C., Schutte S., Velder J., Aksu Y., Krause W. Synthesis and characterization of water-soluble tin-based metallodendrimers. Organometallics 2003, 22(10):2034-2041.
128. Schuster D.I., Wilson S.R., Kirschner A.N., Schinazi R.F., Schluter-Wirtz S., Tharnish P., Barnett T., Ermolieff J., Tang J., Brettreich M., Hirsch A. Evaluation of the anti-HIV potency of a water-soluble dendrimeric fullerene. Proc. Electrochem. Soc. 2000, 9:267-270.
129. Serpe L., Catalano M.G., Cavalli R., Ugazio E., Bosco O., Canaparo R., Muntoni E., Frairia R., Gasco M.R., Eandi M., Zara G.P. Cytotoxicity of anticancer drugs incorporated in solid lipid nanoparticles on HT-29 colorectal cancer cell line. Eur. J. Pharm. Biopharm. 2004, 58(3):673-680.
130. Sijbesma R., Srdanov G., Wudl F., Castoro J.A., Wilkins C., Friedman S.H., DeCamp D.L., Kenyon G.L. Synthesis of a fullerene derivative for the inhibition of HIV enzymes. J. Am. Chem. Soc. 1993, 115(15):6510-6512.
131. Silva A.C., Santos D., Ferreira D.C., Souto E.B. Minoxidil-loaded nanostructured lipid carriers (NLC): characterization and rheological behaviour of topical formulations. Pharmazie 2009, 64(3):177-182.
132. Slater T.F., Cheeseman K.H., Ingold K.U. Carbon tetrachloride toxicity as a model for studying free-radical mediated liver injury. Philos. Trans. R. Soc. Lond. B: Biol. Sci. 1985, 311(1152):633-645.
133. Smith A.M., Dave S., Nie S., True L., Gao X. Multicolor quantum dots for molecular diagnostics of cancer. Expert Rev. Mol. Diag. 2006, 6(2):231-244.
134. Smith B.R., Heverhagen J., Knopp M., Schmalbrock P., Shapiro J., Shiomi M., Moldovan N.I., Ferrari M., Lee S.C. Localization to atherosclerotic plaque and biodistribution of biochemically derivatized superparamagnetic iron oxide nanoparticles (SPIONs) contrast particles for magnetic resonance imaging (MRI). Biomed. Microdevices 2007, 9(5):719-727.
135. Souto E.B., Müller R.H. SLN and NLC for topical delivery of ketoconazole. J. Microencapsul. 2005, 22(5):501-510.
136. Souto E.B., Wissing S.A., Barbosa C.M., Müller R.H. Development of a controlled release formulation based on SLN and NLC for topical clotrimazole delivery. Int. J. Pharm. 2004, 278(1):71-77.
137. Spangler R.S. Insulin administration via liposomes. Diabetes Care 1990, 13(9):911-922.
138. Sparnacci K., Laus M., Tondelli L., Magnani L., Bernardi C. Core-shell microspheres by dispersion polymerization as drug delivery systems. Macromol. Chem. Phys. 2002, 203(10-11):1364-1369.
139. Speiser, P., 1990. Lipidnanopellets als Tragersystem fur Arzneimittel zur perolen Anwendung. European Patent, EP 0167825.
140. Storni T., Kündig T.M., Senti G., Johansen P. Immunity in response to particulate antigen-delivery systems. Adv. Drug Deliv. Rev. 2005, 57(3):333-355.
141. Svenson S., Tomalia D.A. Dendrimers in biomedical applications - reflections on the field. Adv. Drug Deliv. Rev. 2005, 57(15):2106-2129.
142. Takemoto K., Yamamoto Y., Ueda Y., Sumita Y., Yoshida K., Niki Y. Comparative studies on the efficacy of AmBisome and Fungizone in a mouse model of disseminated aspergillosis. J. Antimicrob. Chemother. 2004, 53(2):311-317.
143. Tamber H., Johansen P., Merkle H.P., Gander B. Formulation aspects of biodegradable polymeric microspheres for antigen delivery. Adv. Drug Deliv. Rev. 2005, 57(3):357-376.
144. Templeton A.C., Wuelfing W.P., Murray R.W. Monolayer-protected cluster molecules. Acc. Chem. Res. 2000, 33(1):27-36.
145. Thaxton C.S., Rosi N.L., Mirkin C.A. Optically and chemically encoded nanoparticle materials for DNA and protein detection. MRS Bull. 2005, 30(5):376-380.
146. Thomas T.P., Patri A.K., Myc A., Myaing M.T., Ye J.Y., Norris T.D., Baker J.R. In vitro targeting of synthesized antibody-conjugated dendrimer nanoparticles. Biomacromolecules 2004, 5(6):2269-2274.
147. Thrash T.P., Cagle D.W., Alford J.M., Ehrhardt G.J., Wright K., Mirzadeh S., Wilson L.J. Toward fullerene-based radiopharmaceuticals: high-yield neutron activation of endohedral 165Ho metallofullerenes. Chem. Phys. Lett. 1999, 308(3-4):329-336.
148. Tolia G.T., Choi H.H., Ahsan F. The role of dendrimers in topical drug delivery. Pharm. Tech. 2008, 32(11):88-98.
149. Tomalia D.A., Reyna L.A., Svenson S. Dendrimers as multi-purpose nanodevices for oncology drug delivery and diagnostic imaging. Biochem. Soc. Trans. 2007, 35(1):61-67.
150. Ung T., Liz-Marzan L.M., Mulvaney P. Controlled method for silica coating of silver colloids. Influence of coating on the rate of chemical reactions. Langmuir 1998, 14:3740-3748.
151. Vandamme T.F., Brobeck L. Poly(amidoamine) dendrimers as ophthalmic vehicles for ocular delivery of pilocarpine nitrate and tropicamide. J. Contr. Rel. 2005, 102(1):23-38.
152. Vemuri S., Rhodes C.T. Preparation and characterization of liposomes as therapeutic delivery systems: a review. Pharm. Acta Helv. 1995, 70(2):95-111.
153. Venkateswarlu V., Manjunath K. Preparation, characterization and in vitro release kinetics of clozapine solid lipid nanoparticles. J. Control Release 2004, 95(3):627-638.
154. Wang S., Mamedova N., Kotov N.A., Chen W., Studer J. Antigen antibody immunocomplex from CdTe nanoparticle bioconjugates. Nano Lett. 2002, 2(8):817-822.
155. Whitemore, M., Li, S., Huang, L., 2001. Liposome vectors for in vivo gene delivery. Curr. Protoc. Hum. Genet. 12.8.1-12.8.9.
156. Wiener E.C., Brechbiel M.W., Brothers H., Magin R.L., Gansow O.A., Tomalia D.A., Lauterbur P.C. Dendrimer-based metal chelates: a new class of MRI contrast agents. Magn. Reson. Med. 1994, 31(1):1-8.
157. Wiener E.C., Konda S., Shadron A., Brechbiel M., Gansow O. Targeting dendrimer-chelates to tumors and tumor cells expressing the high-affinity folate receptor. Invest. Radiol. 1997, 32(12):748-754.
158. Willard D.M., Carillo L.L., Jung J., Van Orden A. CdSe-ZnS quantum dots as resonance energy transfer donors in a model protein-protein binding assay. Nano Lett. 2001, 1(9):469-474.
159. Williams R.M., Zipfel W.R., Webb W.W. Multiphoton microscopy in biological research. Curr. Opin. Chem. Biol. 2001, 5(5):603-608.
160. Wissing S.A., Kayser O., Müller R.H. Solid lipid nanoparticles for parenteral drug delivery. Adv. Drug Deliv. Rev. 2004, 56(9):1257-1272.
161. Wong H.L., Rauth A.M., Bendayan R.A., Manias J.L., Ramaswamy M., Liu Z., Erhan S.Z., Wu X.Y. New polymer-lipid hybrid nanoparticle system increases cytotoxicity of doxorubicin against multidrug-resistant human breast cancer cells. Pharm. Res. 2006, 23(7):1574-1585.
162. Xia Y., Gates B., Yin Y., Lu Y. Monodispersed colloidal spheres: old materials with new applications. Adv. Mater. 2000, 12(10):693-713.
163. Yang L.J., Li Y.B. Simultaneous detection of Escherichia coli O157:H7 and Salmonella Typhimurium using quantum dots as fluorescence labels. Analyst 2006, 131(3):394-401.
164. Yang S.C., Lu L.F., Cai Y., Zhu J.B., Liang B.W., Yang C.Z. Body distribution in mice of intravenously injected camptothecin solid lipid nanoparticles and targeting effect on brain. J. Contr. Rel. 1999, 59(3):299-307.
165. Yoo M.K., Kim I.Y., Kim E.M., Jeong H.J., Lee C.M., Jeong Y.Y., Akaike T., Cho C.S. Superparamagnetic iron oxide nanoparticles coated with galactose-carrying polymer for hepatocyte targeting. J. Biomed. Biotechnol. 2007, 10:94740.
166. Yuki Y., Kiyono H. New generation of mucosal adjuvants for the induction of protective immunity. Rev. Med. Virol. 2003, 13(5):293-310.
167. Zhang L., Granick S. How to stabilize phospholipid liposomes (using nanoparticles). Nano Lett. 2006, 6(4):694-698.
168. Zhang L., Pornpattananangkul D., Hu C.M.J., Huang C.M. Development of nanoparticles for antimicrobial drug delivery. Curr. Med. Chem. 2010, 17(6):585-594.
169. Zhu L., Ang S., Liu W.T. Quantum dots as a novel immunofluorescent detection system for Cryptosporidium parvum and Giardia lamblia. Appl. Environ. Microbiol. 2004, 70(1):597-598.
170. Zhuo R.X., Du B., Lu Z.R. In vitro release of 5-fluorouracil with cyclic core dendritic polymer. J. Contr. Rel. 1999, 57(3):249-257.
171. zur Mühlen, A., 1996. Feste Lipid-Nanopartikel mit prolongierter Wirkstoffliberation: Herstellung, Langzeitstabilitat, Charakterisierung, Freisetzungsverhalten und mechanismen. Ph.D. thesis, Free University of Berlin.
172. zur Mühlen A., Mehnert W. Drug release and release mechanism of prednisolone loaded solid lipid nanoparticles. Pharmazie 1998, 53:552-555.
173. zur Mühlen A., Schwarz C., Mehnert W. Solid lipid nanoparticles (SLN) for controlled drug delivery-drug release and release mechanism. Eur. J. Pharm. Biopharm. 1998, 45(2):149-155.
174. zur Mühlen A., von Elverfeldt D., Bassler N., Neudorfer I., Steitz B., Petri-Fink A., Hofmann H., Bode C., Peter K. Superparamagnetic iron oxide binding and uptake as imaged by magnetic resonance is mediated by the integrin receptor Mac-1 (CD11b/CD18): implications on imaging of atherosclerotic plaques. Atherosclerosis 2007, 193(1):102-111.